Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mirabegron”

156 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 156 results

Large-scale testing (Phase 3)Study completedNCT00840645
What this trial is testing

A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients

Who this might be right for
Urinary Bladder, Overactive
Astellas Pharma Inc 204
Early research (Phase 1)Study completedNCT02127034
What this trial is testing

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects

Who this might be right for
Healthy SubjectsPharmacokineticsDrug-Drug Interaction (DDI)
Astellas Pharma Europe B.V. 26
Not applicableStudy completedNCT02386072
What this trial is testing

A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)

Who this might be right for
Urinary Bladder OveractiveOveractive BladderUrinary Bladder Diseases+1 more
Astellas Scientific & Medical Affairs, Inc. 1,524
Post-approval studies (Phase 4)Study completedNCT04501640
What this trial is testing

Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants

Who this might be right for
Pharmacokinetics of MirabegronFood EffectHealthy Chinese Subjects
Astellas Pharma China, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT02744430
What this trial is testing

Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain

Who this might be right for
Ureteral ObstructionFlank Pain
Baylor College of Medicine 33
Large-scale testing (Phase 3)Study completedNCT00912964
What this trial is testing

Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

Who this might be right for
Urinary Bladder, Overactive
Astellas Pharma Inc 2,030
Testing effectiveness (Phase 2)Study completedNCT03106623
What this trial is testing

Study of ONO-8577 in Patients With Overactive Bladder

Who this might be right for
Overactive Bladder
Ono Pharmaceutical Co., Ltd. 207
Testing effectiveness (Phase 2)Study completedNCT02916693
What this trial is testing

Mirabegron For Erectile Dysfunction

Who this might be right for
Erectile DysfunctionOveractive BladderUrinary Incontinence
Johns Hopkins University 20
Large-scale testing (Phase 3)Study completedNCT02476175
What this trial is testing

Add-on Mirabegron in Pediatric Patients With Refractory Overactive Bladder

Who this might be right for
Overactive BladderUrinary Incontinence
CHU de Quebec-Universite Laval 35
Post-approval studies (Phase 4)Study completedNCT02095665
What this trial is testing

Ureteral Stent-related Pain and Mirabegron (SPAM) Trial

Who this might be right for
Nephrolithiasis
Nova Scotia Health Authority 22
Not applicableUnknownNCT04693897
What this trial is testing

Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and as a Urinary Biomarker

Who this might be right for
Overactive Bladder SyndromeDetrusor Overactivity
Chang Gung Memorial Hospital 400
Early research (Phase 1)Study completedNCT00965926
What this trial is testing

Investigate the Food Effect on the Pharmacokinetics of YM178 in Healthy, Non-elderly Volunteers

Who this might be right for
Healthy VolunteerPharmacokinetics of YM178
Astellas Pharma Inc 72
Early research (Phase 1)Study completedNCT01489696
What this trial is testing

Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin

Who this might be right for
CardiovascularHealthy SubjectsPharmacokinetics
Astellas Pharma Inc 48
Not applicableStudy completedNCT04420533
What this trial is testing

Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron in Sexually Active Men With OAB Symptoms

Who this might be right for
Urinary Bladder, OveractiveSexual BehaviorSexual Activity+2 more
Chang Gung Memorial Hospital 150
Not applicableStudy completedNCT02622555
What this trial is testing

Cardiovascular Morbidity During Treatment of Overactive Bladder With B3 Agonists

Who this might be right for
Overactive Bladder
Karolinska Institutet 221
Not applicableStudy completedNCT07018934
What this trial is testing

Alfuzosin and Mirabegron for Double-J Stent Symptoms

Who this might be right for
Ureteral Stent-Related Symptoms
University of Gaziantep 100
Testing effectiveness (Phase 2)Looking for participantsNCT05369351
What this trial is testing

Efficacy and Safety of Mirabegron in Intracerebral Hemorrhage

Who this might be right for
Intracerebral Haemorrhage
Tianjin Medical University General Hospital 25
Large-scale testing (Phase 3)UnknownNCT04023253
What this trial is testing

Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin

Who this might be right for
Overactive Bladder Syndrome
Far Eastern Memorial Hospital 120
Post-approval studies (Phase 4)UnknownNCT05452434
What this trial is testing

Mirabegron Combined With Behavioral Intervention for Overactive Bladder：a Prospective Multicenter Randomized Controlled Clinical Study

Who this might be right for
Overactive Bladder
Peking Union Medical College Hospital 600
Large-scale testing (Phase 3)Study completedNCT00662909
What this trial is testing

Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

Who this might be right for
Urinary Bladder, Overactive
Astellas Pharma Inc 2,149
Load More Results